Arriving in the arena of weight management treatment, retatrutide presents a unique method. Unlike many existing medications, retatrutide works as a twin agonist, concurrently engaging both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. The concurrent activation promotes several helpful effects, su